hearing loss – Medxy AI

Beyond Binary: A 4-Stage Risk Stratification Tool Transforms Cochlear Implant Candidacy Assessment

By MedXY 04/02/2026

Researchers developed a novel 4-level classification system using routine audiometric data to estimate cochlear implant candidacy likelihood, moving beyond traditional binary screening approaches to support personalized shared decision-making in clinical practice.

news Otorhinolaryngology

Hearing Loss Delays Semantic Prediction When Listening Is Demanding: Two-Stage Prediction Impaired by Cognitive Load

By MedXY 11/04/2025

A visual-world eye-tracking study in older adults shows that postlingual hearing loss delays verb-driven semantic prediction—especially under higher listening demand—while simple agent-based prediction is preserved.

Diabetes & Endocrinology news Otorhinolaryngology

Type 2 Diabetes Quadruples Risk of Hearing Loss — Meta-analysis Finds Predominant High-Frequency Impairment and Links to Duration and HbA1c

By MedXY 11/04/2025

A PRISMA systematic review and meta-analysis of 17 studies (2019–2024) found type 2 diabetes is associated with a 4.19-fold greater odds of hearing loss, especially at high frequencies; duration >10 years and higher HbA1c amplified risk.

news Otorhinolaryngology Pediatrics

DB-OTO Gene Therapy: A Breakthrough Treatment for OTOF-Related Inherited Deafness in Children

By MedXY 10/24/2025

Regeneron's DB-OTO gene therapy shows promising results in restoring natural hearing in children with profound hearing loss caused by OTOF gene mutations, with 75% achieving significant hearing improvement after a single treatment.